✦ LIBER ✦

Radiolabeled RGD-DTPA-Tyr 3 -Octreotate for Receptor-Targeted Radionuclide Therapy

✍ Scribed by Bernard, Bert; Capello, Astrid; van Hagen, Martin; Breeman, Wout; Srinivasan, Ananth; Schmidt, Michelle; Erion, Jack; van Gameren, Arthur; Krenning, Eric; De Jong, Marion

Book ID: 120185046
Publisher: Mary Ann Liebert
Year: 2004
Tongue: English
Weight: 221 KB
Volume: 19
Category: Article
ISSN: 1084-9785
DOI: 10.1089/108497804323071940

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[177Lu-DOTA0,Tyr3]octreotate for somatos

[177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy

✍ Marion de Jong; Wout A.P. Breeman; Bert F. Bernard; Willem H. Bakker; Michael Sc 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 243 KB

Hormonal crises following receptor radio

Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate

✍ Bart de Keizer; Maarten O. van Aken; Richard A. Feelders; Wouter W. de Herder; B 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 157 KB

Pre-clinical comparison of [DTPA0] octre

Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy

✍ Marion De Jong; Willem H. Bakker; Wout A. P. Breeman; Bert F. Bernard; Leo J. Ho 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 124 KB

We have evaluated the potential usefulness of radiolabelled [DTPA 0 ,Tyr 3 ]octreotide and [DOTA 0 ,Tyr 3 ]octreotide as radiopharmaceuticals for somatostatin receptor-targeted scintigraphy and radiotherapy. In vitro somatostatin receptor binding and in vivo metabolism in rats of the compounds were

Bone marrow dosimetry in peptide recepto

Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

✍ Flavio Forrer; Eric P. Krenning; Peter P. Kooij; Bert F. Bernard; Mark Konijnenb 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 219 KB

Amifostine protects rat kidneys during p

Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

✍ Edgar J. Rolleman; Flavio Forrer; Bert Bernard; Magda Bijster; Marcel Vermeij; R 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 218 KB

Yttrium-90 and indium-111 labelling, rec

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

✍ Marion de Jong, Willem H. Bakker, Eric P. Krenning… 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 490 KB